Silverberg, J., S. Barbarot, M. Gooderham, J. Simon, E. Simpson, A. Kurbasic, C. Olsen, and M. Cork. ‚ÄúSpecifically Targeting Interleukin-13 With Tralokinumab Improved Sleep in Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials in Patients With Atopic Dermatitis‚ÄĚ. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 1, Jan. 2021, p. s9, doi:10.25251/skin.5.supp.9.